Thompson Rubinstein Investment Management’s Biogen BIIB Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$7.86M	Sell	33,252 -111	-0.3%	-$35K	2.53%	13
2018 Q4	$10M	Buy	33,363 +19	+0.1%	+$6.06K	3.7%	7
2018 Q3	$11.8M	Sell	33,344 -65	-0.2%	-$22.4K	3.61%	6
2018 Q2	$9.7M	Sell	33,409 -345	-1%	-$97K	3.24%	7
2018 Q1	$9.24M	Buy	33,754 +494	+1%	+$153K	3.14%	9
2017 Q4	$10.6M	Sell	33,260 -162	-0.5%	-$52K	3.49%	7
2017 Q3	$10.5M	Hold	33,422	–	–	3.65%	5
2017 Q2	$9.07M	Sell	33,422 -325	-1%	-$85.9K	3.34%	6
2017 Q1	$9.23M	Sell	33,747 -1,051	-3%	-$297K	3.35%	8
2016 Q4	$9.87M	Buy	34,798 +50	+0.1%	+$14.8K	3.66%	3
2016 Q3	$10.9M	Sell	34,748 -215	-0.6%	-$63.7K	4.13%	3
2016 Q2	$8.46M	Buy	34,963 +5,172	+17%	+$1.36M	3.29%	8
2016 Q1	$7.75M	Buy	+29,791	New	+$7.87M	3.16%	9

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thompson Rubinstein Investment Management's BIIB Position: Q1 2019 in Review

Thompson Rubinstein Investment Management reduced its Biogen (BIIB) stake by 0.33% in Q1 2019, selling an estimated $35K and leaving 33,252 shares worth $7.86M. The position accounts for 2.53% of the portfolio, ranked #13.

Thompson Rubinstein Investment Management first reported a position in BIIB in Q1 2016 and has held it in 13 quarters since. The position peaked at $11.8M in Q3 2018. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Thompson Rubinstein Investment Management held 33,252 shares of Biogen worth $7.86M as of Q1 2019.
Thompson Rubinstein Investment Management sold 111 Biogen shares in Q1 2019, an estimated $35K.
Biogen made up 2.53% of Thompson Rubinstein Investment Management's portfolio in Q1 2019, its #13 holding.
Thompson Rubinstein Investment Management first reported a position in Biogen in Q1 2016 and has held it in 13 quarters since.
Thompson Rubinstein Investment Management's Biogen position peaked at $11.8M in Q3 2018.
1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2019, filed 4 Apr 2019.